Patent ID: 11896614
Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 8:
9. The method of claim 1, wherein:
(i) the immune effector cell population suitable for use in a CAR therapy shows an increased absolute T cell count (ATC), compared to a reference value; or
(ii) the immune effector cell population suitable for use in a CAR therapy comprises one or more of an absolute T cell count of at least 400 cells/microliter, an absolute naïve T cell count of at least 200 cells/microliter, an absolute stem central memory T cell count of at least 20 cells/microliter, or an absolute central memory T cell count of at least 40 cells/microliter.